dr. devarakonda on biomarkers beyond pd-l1 in nsclc
Published 7 years ago • 575 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:03
dr. costa on biomarkers beyond pd-l1 for immunotherapy in nsclc
-
2:13
the value of pd-l1 as a biomarker beyond lung cancers
-
1:24
dr. lilenbaum on pd-l1 as a predictive biomarker for immunotherapy in lung cancer
-
1:42
dr. gandara discusses pd-l1 as a biomarker in lung cancer
-
7:34
pd-l1 as a biomarker in squamous non-small cell lung cancer
-
1:21
dr. kim discusses pd-l1 as a biomarker in lung cancer
-
4:41
beyond pd-l1: in search of better biomarkers
-
5:02
dr blythe adamson: pd-l1 as a predictive biomarker in lung cancer continues to evolve
-
1:14
dr. levy on investigational biomarkers of response to immunotherapy in nsclc
-
1:03
dr. barbara j. gitlitz on why pd-l1 is not a good biomarker for immunotherapy in lung cancer
-
3:43
biomarkers in nsclc: a pathologist's insight into pd-l1 and tmb
-
1:00
dr. nadler discusses role of pd-l1 in squamous nsclc
-
2:24
dr. weiss on pd-l1 biomarker in lung cancer
-
1:13
guiding nsclc treatment with biomarkers
-
7:09
personalizing immunotherapy beyond pdl1 expression
-
5:36
immunotherapy in nsclc: an update on biomarkers
-
5:18
pd-l1 expression as a biomarker in renal cell carcinoma
-
4:37
emerging biomarkers in lung cancer
-
1:14
dr. gupta on pd-l1 as a biomarker in kidney cancer